Lancet

Lancet

柳叶刀

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Lancet》是由Elsevier Ltd出版社于1823年创办的英文国际期刊(ISSN: 0140-6736,E-ISSN: 1474-547X),该期刊长期致力于医学:内科领域的创新研究,主要研究方向为医学-医学:内科。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.1541...%),以发表医学:内科领域等方向的原创性研究为核心(研究类文章占比76.15%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在218篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Lancet审稿周期约为 约3月 。该刊近年未被列入国际预警名单,年发文量约218篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 218 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
MEDICINE, GENERAL & INTERNAL 医学:内科
1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
MEDICINE, GENERAL & INTERNAL 医学:内科
1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, GENERAL & INTERNAL SCIE Q1 1 / 325

99.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, GENERAL & INTERNAL SCIE Q1 2 / 329

99.54%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:148.1 SJR:12.113 SNIP:23.15
学科类别 分区 排名 百分位
大类:Medicine 小类:General Medicine Q1 1 / 636

99%

期刊发文

  • Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

    Author: Hurvitz, Sara A.; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Wing Yan; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, Jose Manuel; Kim, Sung-Bae; Petry, Vanessa; Huang, Chiun-Sheng; Li, Wei; Frenel, Jean-Sebastien; Antolin, Silvia; Yeo, Winnie; Bianchini, Giampaolo; Loi, Sherene; Tsurutani, Junji; Egorov, Anton; Liu, Yali; Cathcart, Jillian; Ashfaque, Shahid; Cortes, Javier

    Journal: LANCET. 2023; Vol. 401, Issue 10371, pp. 105-117. DOI: 10.1016/S0140-6736(22)02420-5

  • Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferioritytrial

    Author: Wang, Yongjun; Li, Shuya; Pan, Yuesong; Li, Hao; Parsons, Mark W.; Campbell, Bruce C., V; Schwamm, Lee H.; Fisher, Marc; Che, Fengyuan; Dai, Hongguo; Li, Deyang; Li, Runhui; Wang, Junhai; Wang, Yilong; Zhao, Xingquan; Li, Zixiao; Zheng, Huaguang; Xiong, Yunyun; Meng, Xia

    Journal: LANCET. 2023; Vol. 401, Issue 10377, pp. 645-654. DOI: 10.1016/S0140-6736(22)02600-9

  • Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis

    Author: Pan, Yang; Wang, Liang; Feng, Zhaomin; Xu, Hui; Li, Fu; Shen, Ying; Zhang, Daitao; Liu, William J.; Gao, George F.; Wang, Quanyi

    Journal: LANCET. 2023; Vol. 401, Issue 10377, pp. 664-672. DOI: 10.1016/S0140-6736(23)00129-0

  • Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

    Author: Kimball, Alexa B.; Jemec, Gregor B. E.; Alavi, Afsaneh; Reguiai, Ziad; Gottlieb, Alice B.; Bechara, Falk G.; Paul, Carle; Bourboulis, Evangelos J. Giamarellos; Villani, Axel P.; Schwinn, Andreas; Rueff, Franziska; Ramaya, Larisha Pillay; Reich, Adam; Lobo, Ines; Sinclair, Rodney; Passeron, Thierry; Martorell, Antonio; Mendes-Bastos, Pedro; Kokolakis, Georgios; Becherel, Pierre-Andre; Wozniak, Magdalena B.; Martinez, Angela Llobet; Wei, Xiaoling; Uhlmann, Lorenz; Passera, Anna; Keefe, Deborah; Martin, Ruvie; Field, Clarice; Chen, Li; Vandemeulebroecke, Marc; Ravichandran, Shoba; Muscianisi, Elisa

    Journal: LANCET. 2023; Vol. 401, Issue 10378, pp. 747-761. DOI: 10.1016/S0140-6736(23)00022-3

  • Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

    Author: You, Rui; Liu, You -Ping; Xie, Yu -Long; Lin, Chao; Duan, Chong -Yang; Chen, Dong-Ping; Pan, Yi; Qi, Bin; Zou, Xiong; Guo, Ling; Cao, Jing-Yu; Zhang, Yi-Nuan; Wang, Zhi-Qiang; Liu, Yong -Long; Ouyang, Yan-Feng; Wen, Kai; Yang, Qi; Xie, Ruo-Qi; Li, Hui-Feng; Duan, Xiao-Tong; Ding, Xi; Peng, Lan; Chen, Si -Yuan; Liang, Jiong-Lin; Feng, Zheng-Kai; Xia, Tian-Liang; Xie, Rui-Ling; Jiang, Rou; Gu, Chen-Mei; Liu, Rong-Zeng; Sun, Rui; Yang, Xin; Liu, Li-Zhi; Ling, Li; Liu, Qing; Ng, Wai Tong; Hua, Yi-Jun; Huang, Pei-Yu; Chen, Ming-Yuan

    Journal: LANCET. 2023; Vol. 401, Issue 10380, pp. 917-927. DOI: 10.1016/S0140-6736(23)00269-6

  • Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomisedtrial

    Author: He, Jiang; Ouyang, Nanxiang; Guo, Xiaofan; Sun, Guozhe; Li, Zhao; Mu, Jianjun; Wang, Dao Wen; Qiao, Lixia; Xing, Liying; Ren, Guocheng; Zhao, Chunxia; Yang, Ruihai; Yuan, Zuyi; Wang, Chang; Shi, Chuning; Liu, Songyue; Miao, Wei; Li, Guangxiao; Chen, Chung-Shiuan; Sun, Yingxian; CRHCP Study Grp

    Journal: LANCET. 2023; Vol. 401, Issue 10380, pp. 928-938. DOI: 10.1016/S0140-6736(22)02603-4

  • Malnutrition in older adults

    Author: Dent, Elsa; Wright, Olivia R. L.; Woo, Jean; Hoogendijk, Emiel O.

    Journal: LANCET. 2023; Vol. 401, Issue 10380, pp. 951-966. DOI: 10.1016/S0140-6736(22)02612-5

  • Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial

    Author: Mingguang He, Yuzhen Jiang, Shengsong Huang, Dolly S Chang, Beatriz Munoz, Tin Aung, Paul J Foster, David S Friedman

    Journal: LANCET, 2019, Vol., , DOI:10.1016/s0140-6736(18)32607-2